English  |  正體中文  |  简体中文  |  总笔数 :0  
造访人次 :  52343917    在线人数 :  1140
教育部委托研究计画      计画执行:国立台湾大学图书馆
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
关于TAIR

浏览

消息

著作权

相关连结

"hung j s"的相关文件

回到依作者浏览
依题名排序 依日期排序

显示项目 11-35 / 109 (共5页)
1 2 3 4 5 > >>
每页显示[10|25|50]项目

机构 日期 题名 作者
臺大學術典藏 2021-08-31T06:42:23Z Oxaliplatin-based chemotherapy is more beneficial in KRAS mutant than in KRAS wild-type metastatic colorectal cancer patients Lin Y.-.; Liang Y.-H.; Tsai J.-H.; Liau J.-Y.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Lin L.-I.; Tseng L.-H.; Chang Y.-L.; Yeh K.-H.; ANN-LII CHENG
臺大學術典藏 2021-08-31T06:29:50Z Cetuximab might be detrimental to metastatic colorectal cancer patients with KRAS codon 12 mutations Liang Y.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Tseng L.-H.; Lin L.-I.; Chang Y.-L.; ANN-LII CHENG; Yeh K.-H.
臺大學術典藏 2021-08-31T06:29:44Z BRAF mutation may have different prognostic implications in early- and late-stage colorectal cancer Chen K.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; Tseng L.-H.; Lin L.-I.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Chang Y.-L.; Yeh K.-H.; ANN-LII CHENG
臺大學術典藏 2021-08-20T02:45:42Z BRAF mutation may have different prognostic implications in early- and late-stage colorectal cancer KUO-HSING CHEN; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; Tseng L.-H.; Lin L.-I.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Chang Y.-L.; Yeh K.-H.; Cheng A.-L.
臺大學術典藏 2021-05-27T08:20:55Z Serum vascular adhesion protein-1 predicts all-cause mortality and cancer-related mortality in subjects with colorectal cancer Li Y.-I.; Hung J.-S.; Yu T.-Y.; JYH-MING LIOU; Wei J.-N.; Kao H.-L.; Chuang L.-M.; Shun C.-T.; Lee P.-H.; Lai H.-S.; Su C.-Y.; Li H.-Y.; Liang J.-T.
臺大學術典藏 2021-05-07T02:46:38Z Oxaliplatin-based chemotherapy is more beneficial in KRAS mutant than in KRAS wild-type metastatic colorectal cancer patients Lin Y.-.; YI-HSIN LIANG; Tsai J.-H.; Liau J.-Y.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Lin L.-I.; Tseng L.-H.; Chang Y.-L.; Yeh K.-H.; Cheng A.-L.
臺大學術典藏 2021-05-07T02:46:37Z Cetuximab might be detrimental to metastatic colorectal cancer patients with KRAS codon 12 mutations YI-HSIN LIANG; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Tseng L.-H.; Lin L.-I.; Chang Y.-L.; Cheng A.-L.; Yeh K.-H.
臺大學術典藏 2021-05-03T02:21:01Z Oxaliplatin-based chemotherapy might provide longer progression-free survival in KRAS mutant metastatic colorectal cancer Lin Y.-L.; Liau J.-Y.; Yu S.-C.; Tseng L.-H.; Lin L.-I.; JIN-TUNG LIANG; Lin B.-R.; Hung J.-S.; Chang Y.-L.; Yeh K.-H.; Cheng A.-L.
臺大學術典藏 2021-05-03T02:21:00Z The molecular chaperone cosmc enhances malignant behaviors of colon cancer cells via activation of Akt and ERK Huang J.; Che M.-I.; Lin N.-Y.; Hung J.-S.; Huang Y.-T.; Lin W.-C.; Huang H.-C.; Lee P.-H.; JIN-TUNG LIANG; Huang M.-C.
臺大學術典藏 2021-05-03T02:20:59Z β1, 4-N-acetylgalactosaminyltransferase III modulates cancer stemness through EGFR signaling pathway in colon cancer cells Che M.-I.; Huang J.; Hung J.-S.; Lin Y.-C.; Huang M.-J.; Lai H.-S.; Hsu W.-M.; JIN-TUNG LIANG; Huang M.-C.
臺大學術典藏 2021-05-03T02:20:58Z C1GALT1 overexpression promotes the invasive behavior of colon cancer cells through modifying o-glycosylation of FGFR2 Hung J.-S.; Huang J.; Lin Y.-C.; Huang M.-J.; Lee P.-H.; Lai H.-S.; JIN-TUNG LIANG; Huang M.-C.
臺大學術典藏 2021-05-03T02:20:57Z Oxaliplatin-based chemotherapy is more beneficial in KRAS mutant than in KRAS wild-type metastatic colorectal cancer patients Lin Y.-.; Liang Y.-H.; Tsai J.-H.; Liau J.-Y.; JIN-TUNG LIANG; Lin B.-R.; Hung J.-S.; Lin L.-I.; Tseng L.-H.; Chang Y.-L.; Yeh K.-H.; Cheng A.-L.
臺大學術典藏 2021-05-03T02:20:57Z Serum vascular adhesion protein-1 predicts all-cause mortality and cancer-related mortality in subjects with colorectal cancer Li Y.-I.; Hung J.-S.; Yu T.-Y.; Liou J.-M.; Wei J.-N.; Kao H.-L.; Chuang L.-M.; Shun C.-T.; Lee P.-H.; Lai H.-S.; Su C.-Y.; Li H.-Y.; JIN-TUNG LIANG
臺大學術典藏 2021-05-03T02:20:56Z β-1,4-Galactosyltransferase III suppresses β1 integrin-mediated invasive phenotypes and negatively correlates with metastasis in colorectal cancer Chen C.-H.; Wang S.-H.; Liu C.-H.; Wu Y.-L.; Wang W.-J.; Huang J.; Hung J.-S.; Lai I.-R.; JIN-TUNG LIANG; Huang M.-C.
臺大學術典藏 2021-05-03T02:20:55Z Cetuximab might be detrimental to metastatic colorectal cancer patients with KRAS codon 12 mutations Liang Y.-H.;Lin Y.-L.;Liau J.-Y.;Tsai J.-H.;Jin-Tung Liang;Lin B.-R.;Hung J.-S.;Tseng L.-H.;Lin L.-I.;Chang Y.-L.;Cheng A.-L.;Yeh K.-H.; Liang Y.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; JIN-TUNG LIANG; Lin B.-R.; Hung J.-S.; Tseng L.-H.; Lin L.-I.; Chang Y.-L.; Cheng A.-L.; Yeh K.-H.
臺大學術典藏 2021-05-03T02:20:53Z BRAF mutation may have different prognostic implications in early- and late-stage colorectal cancer Chen K.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; Tseng L.-H.; Lin L.-I.; JIN-TUNG LIANG; Lin B.-R.; Hung J.-S.; Chang Y.-L.; Yeh K.-H.; Cheng A.-L.
臺大學術典藏 2021-05-03T02:20:49Z Long-term follow-up for patients with colonic perforation due to colonoscopy: From clinical and medicolegal viewpoints Chen T.-C.; Hung J.-S.; Lin B.-R.; Huang J.; JIN-TUNG LIANG
臺大學術典藏 2021-05-03T02:20:45Z The Toldt fascia: A historic review and surgical implications in complete mesocolic excision for colon cancer Jin-Tung Liang;Huang J.;Chen T.-C.;Hung J.-S.; JIN-TUNG LIANG; Huang J.; Chen T.-C.; Hung J.-S.
臺大學術典藏 2021-04-29T07:30:24Z C1GALT1 is associated with poor survival and promotes soluble Ephrin A1-mediated cell migration through activation of EPHA2 in gastric cancer Lee P.-C.;Chen S.-T.;Kuo T.-C.;Lin T.-C.;Lin M.-C.;Huang J.;Hung J.-S.;Hsu C.-L.;Juan H.-F.;Po-Huang Lee;Huang M.-C.; Lee P.-C.; Chen S.-T.; Kuo T.-C.; Lin T.-C.; Lin M.-C.; Huang J.; Hung J.-S.; Hsu C.-L.; Juan H.-F.; PO-HUANG LEE; Huang M.-C.
臺大學術典藏 2021-03-18T02:02:44Z Serum vascular adhesion protein-1 predicts all-cause mortality and cancer-related mortality in subjects with colorectal cancer Li Y.-I.; Hung J.-S.; Yu T.-Y.; Liou J.-M.; Wei J.-N.; Kao H.-L.; Chuang L.-M.; CHIA-TUNG SHUN; Lee P.-H.; Lai H.-S.; Su C.-Y.; Li H.-Y.; Liang J.-T.
臺大學術典藏 2021-03-05T06:07:30Z Is surgery indicated for patients with symptomatic nonfunctioning pancreatic neuroendocrine tumor and unresectable hepatic metastases? Hung J.-S.; MING-CHU CHANG; Lee P.-H.; Tien Y.-W.
臺大學術典藏 2021-03-03T03:01:04Z MUC20 overexpression predicts poor prognosis and enhances EGF-induced malignant phenotypes via activation of the EGFR-STAT3 pathway in endometrial cancer Chen C.-H.;Wang S.-W.;Chen C.-W.;Huang M.-R.;Hung J.-S.;Huang H.-C.;Ho-Hsiung Lin;Chen R.-J.;Shyu M.-K.;Huang M.-C.; Chen C.-H.; Wang S.-W.; Chen C.-W.; Huang M.-R.; Hung J.-S.; Huang H.-C.; HO-HSIUNG LIN; Chen R.-J.; Shyu M.-K.; Huang M.-C.
臺大學術典藏 2021-01-28T01:06:38Z Oxaliplatin-based chemotherapy might provide longer progression-free survival in KRAS mutant metastatic colorectal cancer Lin Y.-L.;Liau J.-Y.;Yu S.-C.;Tseng L.-H.;Lin L.-I.;Liang J.-T.;Lin B.-R.;Hung J.-S.;Chang Y.-L.;Kun-Huei Yeh;Cheng A.-L.; Lin Y.-L.; Liau J.-Y.; Yu S.-C.; Tseng L.-H.; Lin L.-I.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Chang Y.-L.; KUN-HUEI YEH; Cheng A.-L.
臺大學術典藏 2021-01-28T01:06:32Z Oxaliplatin-based chemotherapy is more beneficial in KRAS mutant than in KRAS wild-type metastatic colorectal cancer patients Lin Y.-.;Liang Y.-H.;Tsai J.-H.;Liau J.-Y.;Liang J.-T.;Lin B.-R.;Hung J.-S.;Lin L.-I.;Tseng L.-H.;Chang Y.-L.;Kun-Huei Yeh;Cheng A.-L.; Lin Y.-.; Liang Y.-H.; Tsai J.-H.; Liau J.-Y.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Lin L.-I.; Tseng L.-H.; Chang Y.-L.; KUN-HUEI YEH; Cheng A.-L.
臺大學術典藏 2021-01-28T01:06:29Z Cetuximab might be detrimental to metastatic colorectal cancer patients with KRAS codon 12 mutations Liang Y.-H.;Lin Y.-L.;Liau J.-Y.;Tsai J.-H.;Liang J.-T.;Lin B.-R.;Hung J.-S.;Tseng L.-H.;Lin L.-I.;Chang Y.-L.;Cheng A.-L.;Kun-Huei Yeh; Liang Y.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Tseng L.-H.; Lin L.-I.; Chang Y.-L.; Cheng A.-L.; KUN-HUEI YEH

显示项目 11-35 / 109 (共5页)
1 2 3 4 5 > >>
每页显示[10|25|50]项目